RARE- Ultragenyx Pharmaceutical Inc.

Name: Ultragenyx Pharmaceutical Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ultragenyx Pharmaceutical Inc. (RARE) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RARE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kakkis Emil D	132.7K	$3.51M	-
CFO	Horn Howard	88.9K	$2.35M	-
Other	Huang Dennis Karl	79.9K	$2.12M	-
Other	Pinion John Richard	79.9K	$2.12M	-
VP	Huizenga Theodore Alan	50.5K	$1.33M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 1, 2022	Huizenga Theodore Alan65	SVP, Chief Accounting Officer	Sell	843	$66.62	$56,160.66	-6.0%	-30.4%	-32.2%
Mar 1, 2022	Huang Dennis Karl63	See Remarks	Sell	3,234	$66.62	$215,449.08	-8.1%	-30.4%	-32.2%
Mar 1, 2022	Parschauer Karah Herdman77	EVP And Chief Legal Officer	Sell	2,886	$66.62	$192,265.32	-10.2%	-30.4%	-32.2%
Mar 1, 2022	Kassberg Thomas Richard68	Cbo &EVP	Sell	2,374	$66.62	$158,155.88	-1.1%	-30.4%	-32.2%
Jan 30, 2022	Bedrosian Camille L64	EVP And Chief Medical Officer	Sell	1,657	$66.30	$109,859.10	-4.3%	+1.1%	-38.5%
Oct 14, 2021	Huang Dennis Karl63	EVP &Chief Tech Ops Officer	Sell	358	$81.14	$29,048.12	-0.9%	-12.1%	-54.2%
Oct 14, 2021	Harris Erik75	EVP &Chief Commercial Officer	Sell	303	$81.14	$24,585.42	-1.2%	-12.1%	-54.2%
Oct 14, 2021	Bedrosian Camille L64	EVP And Chief Medical Officer	Sell	359	$81.14	$29,129.26	-0.9%	-12.1%	-54.2%
Oct 14, 2021	Huizenga Theodore Alan65	SVP, Chief Accounting Officer	Sell	140	$81.14	$11,359.60	-1.0%	-12.1%	-54.2%
Oct 14, 2021	Kassberg Thomas Richard68	Cbo &EVP	Sell	286	$81.14	$23,206.04	-0.1%	-12.1%	-54.2%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC